sertraline has been researched along with Chronic Disease in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (27.87) | 18.2507 |
| 2000's | 20 (32.79) | 29.6817 |
| 2010's | 23 (37.70) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Alexopoulos, GS; Bingham, KS; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Debray, D; Gonzales, E; Thébaut, A | 1 |
| Almansour, MI; Jarrar, BM; Jarrar, YB | 1 |
| Bianco, G; Castelnovo, A; Chiaro, G; Maffei, P; Manconi, M | 1 |
| Abernethy, AP; Agar, M; Clark, K; Currow, DC; Davidson, PM; Doogue, M; Ekström, M; Fazekas, B; Hill, J; Louw, S; McCaffrey, N; McDonald, C; Sajkov, D | 1 |
| Chengfeng, S; Lei, W; Lingjia, Q; Rui, Z; Wei, L; Xinxing, W | 1 |
| Cai, H; Gong, H; Jiang, P; Li, H; Liu, Y; Tang, M; Zhang, L | 1 |
| DeBattista, C; Keller, J; Kocsis, JH; Lazzeroni, LC; Murphy, GM; Ray, A; Ryan, HS; Sarginson, JE; Schatzberg, AF; Tennakoon, L; Trivedi, MH | 1 |
| Hu, J; Liu, J; Liu, Z; Rong, X; Wang, L; Xiao, S; Zhong, Z | 1 |
| Martins, V; Moreira, C; Oliveira, R | 1 |
| Boyle, SH; Hall, R; Jiang, W; Krishnan, R; O'Connor, CM; Prybol, K; Rogers, JG; Steffens, DC; Streilein, RD; Xiong, GL | 1 |
| Bispo, M; Carmo, J; Marques, S | 1 |
| Cohen, J; Debray, D; Gonzales, E; Gottrand, F; Habes, D; Jacquemin, E; Rivet, C; Thébaut, A | 1 |
| Adebayo, AN; Onaolapo, AY; Onaolapo, OJ | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Mendhekar, DN | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Feeny, NC; Mavissakalian, MR; Roy-Byrne, PP; Zoellner, LA | 1 |
| Chaplin, W; Huertas, A; Huertas, SE; Juarbe, D; Perez-Pedrogo, C; Reyes-Rabanillo, ML; Reyes-Rodriguez, ML; Vera, M | 1 |
| Douzenis, A; Flevari, P; Ikonomidis, I; Iliodromitis, E; Kremastinos, DT; Leftheriotis, D; Liapis, C; Lykouras, L; Paraskevaidis, I | 1 |
| Filipcić, I; Jakovljević, M; Margetić, B; Simunović, I | 1 |
| Arias, RM; Callwood, DD; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Rivelli, SK; Silva, SG; Stough, WG; Zakhary, B | 1 |
| Arias, RM; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, CM | 1 |
| Davidson, MB; Echeverry, D | 1 |
| Fillenbaum, GG; Kuchibhatla, MN | 1 |
| Baillie, R; Cuffe, M; Fiuzat, M; Jiang, W; Kaddurah-Daouk, R; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, C; Oken, H; Shaw, LK; Steffens, DC | 1 |
| Fiuzat, M; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Xiong, GL | 1 |
| Misra, S; Singh, NN | 1 |
| Davis, SM; Gniwesch, L; Harrison, W; Howland, R; Klein, DN; Kocsis, JH; Rush, AJ; Schatzberg, A | 1 |
| Cooper, SJ; King, DJ; Lynch, G; Mulholland, C | 1 |
| Harrison, WM; Hirschfeld, RM; Keller, MB; Kornstein, SG; McCullough, JP; Russell, JM; Shea, MT | 1 |
| Hossain, A; Masters, B; Parker, DE; Ruwe, WD; Trautman, RP; Tucker, P; Wyatt, DB | 1 |
| Amsterdam, JD; Ruckenstein, MJ; Staab, JP | 1 |
| Lee, RA; West, RM; Wilson, JD | 1 |
| Blaya, C; Dornelles, M; Heldt, E; Kipper, L; Manfro, GG; Salum, GA; Wachleski, C | 1 |
| Getachew, Y; Handem, I; Jacobe, H; Mayo, MJ; Rush, AJ; Saldana, S | 1 |
| Berger, M; Dykierek, P; Härter, M; Kech, S; Schneider, D; Schramm, E; van Calker, D; Zobel, I | 1 |
| Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
| Gupta, AK; Gupta, MA | 1 |
| Kupfer, DJ | 1 |
| Acquadro, MA; Montgomery, WW | 1 |
| Davidson, J; Fava, M; Halbreich, U; Harrison, W; Kocsis, JH; Koran, L; Rosenbaum, J; Thase, ME | 1 |
| Berti, C; Dinan, TG; Thakore, JH | 1 |
| Berndt, ER; Finkelstein, SN; Greenberg, PE; Keller, MB; Parsley, RA; Russell, JM | 1 |
| Agosti, V; Stewart, JW | 1 |
| Armstrong, A; Bullis, J; Engel, AL; Engel, CC; Walker, EA | 1 |
| Kim, YK; Lee, MS; Lee, SK; Suh, KY | 1 |
| Fawcett, JA; Gelenberg, AJ; Harrison, W; Hirschfeld, R; Keller, MB; Klein, D; Kocsis, JH; Koran, L; Kornstein, S; LaVange, L; McCullough, JP; Rush, AJ; Russell, J; Schatzberg, A; Thase, ME | 1 |
| Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Markowitz, JC; McCullough, JP; Miceli, RJ; Rush, AJ; Schatzberg, AF; Thase, ME | 1 |
| Davis, SM; Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; McCullough, JP; Rush, AJ; Russell, JM; Thase, ME | 1 |
| Davis, SM; Harrison, WM; Keitner, GI; Keller, MB; Klein, DN; Kornstein, SG; Markowitz, JC; Miller, IW; Rush, AJ; Schatzberg, AF; Schlager, DS; Thase, ME | 1 |
| Connolly, MA; Delgado, PL; Fawcett, J; Friedman, RA; Harrison, WM; Hirschfeld, RM; Howland, RH; Koran, LM; Miceli, RJ; Miller, IW; Russell, JM; Thase, ME | 1 |
| Baldessarini, RJ; Viguera, AC | 1 |
| Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB | 1 |
| Berndt, ER; Finkelstein, SN; Gelenberg, AJ; Keller, MB; Koran, LM; Kornstein, SG; Miller, IM; Thase, ME; Trapp, GA | 1 |
| Davis, SM; Gelenberg, AJ; Harrison, WM; Keitner, GI; Keller, MB; Kornstein, SG; McCullough, JP; Schatzberg, AF; Thase, ME; Yonkers, KA | 1 |
| Davis, S; Friedman, ES; Harrison, W; Hirschfeld, RM; Keller, M; Koran, LM; Rush, J; Russell, JM | 1 |
| DeBattista, C; Friedman, RA; Gelenberg, AJ; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, D; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Schatzberg, AF; Thase, ME | 1 |
| Kane, JM | 1 |
| Clary, CM; Endicott, J; Rapaport, MH | 1 |
2 review(s) available for sertraline and Chronic Disease
| Article | Year |
|---|---|
[Physiopathology and management of cholestatic pruritus in children].
Topics: Anion Exchange Resins; Biliary Tract Surgical Procedures; Child; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 CYP3A Inducers; Humans; Liver Transplantation; Narcotic Antagonists; Pruritus; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Sorption Detoxification; Ursodeoxycholic Acid | 2017 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
38 trial(s) available for sertraline and Chronic Disease
| Article | Year |
|---|---|
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Sertraline; Treatment Outcome | 2023 |
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.
Topics: Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Dyspnea; Female; Humans; Male; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome; Visual Analog Scale | 2019 |
Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial.
Topics: Aged; Anthracenes; Antidepressive Agents; Antipsychotic Agents; Anxiety; Chronic Disease; Depression; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2015 |
Sertraline as an Additional Treatment for Cholestatic Pruritus in Children.
Topics: Adolescent; Alagille Syndrome; Child; Child, Preschool; Cholestasis, Intrahepatic; Chronic Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Prospective Studies; Pruritus; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2017 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
Collaborative care for depressed patients with chronic medical conditions: a randomized trial in Puerto Rico.
Topics: Adult; Aged; Antidepressive Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Female; Humans; Interprofessional Relations; Male; Managed Care Programs; Middle Aged; Patient Care Team; Puerto Rico; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Treatment Outcome | 2010 |
Depression treatment and its impact upon the quality of life in patients with diabetes type 2 - the Croatian study.
Topics: Adult; Antidepressive Agents; Chronic Disease; Comorbidity; Croatia; Cross-Sectional Studies; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Personality Inventory; Psychometrics; Quality of Life; Sertraline; Surveys and Questionnaires | 2010 |
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Female; Heart Failure; Humans; Male; Middle Aged; Sertraline | 2010 |
Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Time Factors; Treatment Outcome | 2011 |
Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.
Topics: Aged; Antidepressive Agents; Biomarkers; Cause of Death; Chi-Square Distribution; Chronic Disease; Depressive Disorder, Major; Disease-Free Survival; Down-Regulation; Fatty Acids, Omega-3; Female; Flame Ionization; Heart Failure; Humans; Male; Middle Aged; North Carolina; Prognosis; Proportional Hazards Models; Sertraline; Survival Analysis; Survival Rate; Time Factors | 2012 |
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Comorbidity; Depression; Female; Health Status; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Self Report; Sertraline; Surveys and Questionnaires; Treatment Outcome; Walking | 2012 |
Sertraline in chronic tension-type headache.
Topics: Adult; Chronic Disease; Double-Blind Method; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Treatment Outcome | 2002 |
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
Topics: Adult; Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Female; Health Status; Humans; Longitudinal Studies; Male; Outcome Assessment, Health Care; Personality Inventory; Placebos; Quality of Life; Sertraline; Social Adjustment; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Analysis; Treatment Outcome | 2003 |
Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder.
Topics: Adult; Chronic Disease; Circadian Rhythm; Citalopram; Double-Blind Method; Female; Humans; Hydrocortisone; Interleukin-1; Male; Middle Aged; Neuroimmunomodulation; Receptors, Interleukin-2; Reference Values; Saliva; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2004 |
A prospective trial of sertraline for chronic subjective dizziness.
Topics: Adult; Anxiety Disorders; Chronic Disease; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Stress, Psychological; Treatment Outcome | 2004 |
The response to sertraline in men with chronic pelvic pain syndrome.
Topics: Adolescent; Adult; Antidepressive Agents; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Sertraline; Statistics, Nonparametric; Syndrome; Treatment Outcome | 2005 |
Trauma and defense style as response predictors of pharmacological treatment in panic patients.
Topics: Adult; Chronic Disease; Defense Mechanisms; Female; Humans; Life Change Events; Male; Middle Aged; Panic Disorder; Personality Assessment; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Sertraline as a first-line treatment for cholestatic pruritus.
Topics: Antidepressive Agents; Cholestasis, Intrahepatic; Chronic Disease; Cross-Over Studies; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Pain Measurement; Pilot Projects; Prospective Studies; Pruritus; Sertraline; Treatment Outcome | 2007 |
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Drug Administration Schedule; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Psychotherapy, Group; Sertraline; Treatment Outcome | 2008 |
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Chronic Disease; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Imipramine; Psychiatric Status Rating Scales; Sertraline; Task Performance and Analysis | 1996 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
[Chronic depression in the year 2000: therapeutic hopes. 10th World Congress for Psychiatry. Madrid, 24 August 1996].
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depression; Humans; Placebos; Sertraline | 1996 |
A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain.
Topics: 1-Naphthylamine; Adult; Chronic Disease; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Pain Measurement; Pelvic Pain; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
A double-blind study of adjunctive sertraline in haloperidol-stabilized patients with chronic schizophrenia.
Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Sertraline | 1998 |
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
Topics: Adult; Antidepressive Agents; Chronic Disease; Cost of Illness; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Protocols; Comorbidity; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Follow-Up Studies; Humans; Imipramine; Patient Dropouts; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Patient Selection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Health Status; Humans; Imipramine; Male; Middle Aged; Personal Satisfaction; Personality Inventory; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Surveys and Questionnaires; Treatment Outcome | 1998 |
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Male; Middle Aged; Personality; Probability; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment; Treatment Outcome | 1998 |
Lost human capital from early-onset chronic depression.
Topics: Adult; Age of Onset; Aged; Censuses; Chronic Disease; Cost of Illness; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Income; Male; Middle Aged; Outcome Assessment, Health Care; Regression Analysis; Sertraline; Sex Factors; Treatment Outcome; United States | 2000 |
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Estrogens; Female; Humans; Imipramine; Male; Middle Aged; Patient Dropouts; Placebos; Premenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sex Factors; Treatment Outcome | 2000 |
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Anxiety Disorders; Chronic Disease; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2001 |
Sertraline versus imipramine to prevent relapse in chronic depression.
Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sertraline | 2001 |
Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
Topics: Adaptation, Psychological; Adult; Chronic Disease; Double-Blind Method; Female; Health Status; Humans; Longitudinal Studies; Male; Placebos; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2002 |
21 other study(ies) available for sertraline and Chronic Disease
| Article | Year |
|---|---|
In vivo investigation on the chronic hepatotoxicity induced by sertraline.
Topics: Animals; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Chronic Disease; Cytochrome P-450 Enzyme System; Gene Expression Regulation; Glucose Transporter Type 1; Glucuronosyltransferase; Glycogen; Liver; Male; Rabbits; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Bladder | 2018 |
Severe Chronic Abuse of Zolpidem in Refractory Insomnia.
Topics: Aged; Anticonvulsants; Chronic Disease; Clonazepam; Female; Hospitalization; Humans; Levetiracetam; Pregabalin; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Zolpidem | 2018 |
Hyperhomocysteinemia is a result, rather than a cause, of depression under chronic stress.
Topics: Animals; Behavior, Animal; Betaine-Homocysteine S-Methyltransferase; Chronic Disease; Depression; Disease Models, Animal; Homocysteine; Hyperhomocysteinemia; Male; Methionine; Rats, Wistar; Recombinant Proteins; Sertraline; Stress, Psychological | 2014 |
Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system.
Topics: Animals; Antidepressive Agents; Body Weight; Brain-Derived Neurotrophic Factor; Chronic Disease; Depressive Disorder; Disease Models, Animal; Fatty Acids, Omega-3; Hippocampus; Plasminogen Activator Inhibitor 1; Prefrontal Cortex; Random Allocation; Rats, Sprague-Dawley; Sertraline; Stress, Psychological; Tissue Plasminogen Activator | 2015 |
ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
Topics: Adult; Alleles; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; White People | 2015 |
Psychogenic Cough: A Rare Cause of Chronic Cough.
Topics: Anti-Allergic Agents; Antidepressive Agents; Antitussive Agents; Bronchodilator Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cough; Depression; Female; Humans; Middle Aged; Sertraline; Stress, Psychological | 2015 |
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.
Topics: Aged; Biomarkers; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Heart Failure; Humans; Inflammation; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2015 |
An Unusual Cause of Chronic Diarrhea.
Topics: Adult; Antidiarrheals; Biopsy; Chronic Disease; Colitis, Lymphocytic; Colonoscopy; Diarrhea; Female; Humans; Immunohistochemistry; Loperamide; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm.
Topics: Age Factors; Animals; Anti-Anxiety Agents; Antioxidants; Behavior, Animal; Biomarkers; Brain; Chronic Disease; Corticosterone; Diazepam; Disease Models, Animal; Grooming; Male; Maze Learning; Melatonin; Memory, Short-Term; Mice; Motor Activity; Nitric Oxide; Oxidative Stress; Sertraline; Spatial Memory; Stress, Psychological; Superoxide Dismutase; Time Factors | 2017 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women.
Topics: Adolescent; Adult; Antidepressive Agents; Choice Behavior; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Humans; Implosive Therapy; Interview, Psychological; Middle Aged; Outcome and Process Assessment, Health Care; Patient Participation; Personality Inventory; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Young Adult | 2009 |
The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Topics: Aged; Antidepressive Agents; Chronic Disease; Defibrillators, Implantable; Depression; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Quality of Life; Refractory Period, Electrophysiological; Selective Serotonin Reuptake Inhibitors; Sertraline; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
Topics: Aged; Antidepressive Agents; Chronic Disease; Controlled Clinical Trials as Topic; Depression; Female; Heart Failure; Humans; Inpatients; Male; Middle Aged; Personality Inventory; Prevalence; Psychiatric Status Rating Scales; Remission Induction; Research Design; Sertraline; Severity of Illness Index; Treatment Outcome | 2011 |
Collaborative care for depression and chronic illnesses.
Topics: Antidepressive Agents; Chronic Disease; Cost-Benefit Analysis; Depressive Disorder; Diabetes Mellitus; Glycated Hemoglobin; Humans; Physicians, Primary Care; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Female; Fluoxetine; Humans; Middle Aged; Panic Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Urticaria | 1995 |
Treatment of chronic paranasal sinus pain with minimal sinus disease.
Topics: 1-Naphthylamine; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Desipramine; Humans; Migraine Disorders; Pain; Paranasal Sinuses; Selective Serotonin Reuptake Inhibitors; Sertraline; Sinusitis; Trigeminal Neuralgia | 1996 |
An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sertraline; Treatment Outcome | 1996 |
Relapse of depressive symptoms after discontinuing sertraline.
Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles | 2000 |
Extending indications for long-term pharmacotherapy: opportunities and challenges.
Topics: Bulimia; Chronic Disease; Fluoxetine; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Sertraline | 2002 |